Home
Our Team
The Challenge
The Innovation
News
Contact & Service
News
CureDiab present at ‘LifeScienceNet Düsseldorf meets BioCologne’
CureDiab at the BIO-Europe 2023
CureDiab at the Paris NASH Meeting 2023
License contract signed
alytas therapeutics collaborates with CureDiab
New shareholder structure
Data about hepatoprotective activity of the positive allosteric GABAA-receptor modulator in lipotoxicity-induced injury published!